Arena™ (irbesartan) is an angiotensin II receptor (AT1 subtype) antagonist. Arena™ is available for oral administration in tablets containing 150 mg, or 300 mg of irbesartan.
Arena™ (irbesartan) is indicated for the treatment of essential hypertension. It may be used alone or in combination with other
Nephropathy in Type 2 Diabetic Patients :
Arena™ is indicated for the management of renal disease in patients with hypertension and type 2 diabetes mellitus as part of
antihypertensive medicinal product regimen.
150 mg tablets, box of 30 tablets.
300 mg tablets, box of 30 tablets.